• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄、性别和婚姻状况对成年抑郁症预后的作用:一项个体患者数据荟萃分析。

Role of age, gender and marital status in prognosis for adults with depression: An individual patient data meta-analysis.

机构信息

Research Department of Clinical, Educational & Health Psychology, Centre for Outcomes Research and Effectiveness (CORE), University College London, 1-19 Torrington Place, LondonWC1E 7HB, UK.

iCope - Camden & Islington NHS Foundation Trust, St Pancras Hospital, LondonNW1 0PE, UK.

出版信息

Epidemiol Psychiatr Sci. 2021 Jun 4;30:e42. doi: 10.1017/S2045796021000342.

DOI:10.1017/S2045796021000342
PMID:34085616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7610920/
Abstract

AIMS

To determine whether age, gender and marital status are associated with prognosis for adults with depression who sought treatment in primary care.

METHODS

Medline, Embase, PsycINFO and Cochrane Central were searched from inception to 1st December 2020 for randomised controlled trials (RCTs) of adults seeking treatment for depression from their general practitioners, that used the Revised Clinical Interview Schedule so that there was uniformity in the measurement of clinical prognostic factors, and that reported on age, gender and marital status. Individual participant data were gathered from all nine eligible RCTs (N = 4864). Two-stage random-effects meta-analyses were conducted to ascertain the independent association between: (i) age, (ii) gender and (iii) marital status, and depressive symptoms at 3-4, 6-8,<Vinod: Please carry out the deletion of serial commas throughout the article> and 9-12 months post-baseline and remission at 3-4 months. Risk of bias was evaluated using QUIPS and quality was assessed using GRADE. PROSPERO registration: CRD42019129512. Pre-registered protocol https://osf.io/e5zup/.

RESULTS

There was no evidence of an association between age and prognosis before or after adjusting for depressive 'disorder characteristics' that are associated with prognosis (symptom severity, durations of depression and anxiety, comorbid panic disorderand a history of antidepressant treatment). Difference in mean depressive symptom score at 3-4 months post-baseline per-5-year increase in age = 0(95% CI: -0.02 to 0.02). There was no evidence for a difference in prognoses for men and women at 3-4 months or 9-12 months post-baseline, but men had worse prognoses at 6-8 months (percentage difference in depressive symptoms for men compared to women: 15.08% (95% CI: 4.82 to 26.35)). However, this was largely driven by a single study that contributed data at 6-8 months and not the other time points. Further, there was little evidence for an association after adjusting for depressive 'disorder characteristics' and employment status (12.23% (-1.69 to 28.12)). Participants that were either single (percentage difference in depressive symptoms for single participants: 9.25% (95% CI: 2.78 to 16.13) or no longer married (8.02% (95% CI: 1.31 to 15.18)) had worse prognoses than those that were married, even after adjusting for depressive 'disorder characteristics' and all available confounders.

CONCLUSION

Clinicians and researchers will continue to routinely record age and gender, but despite their importance for incidence and prevalence of depression, they appear to offer little information regarding prognosis. Patients that are single or no longer married may be expected to have slightly worse prognoses than those that are married. Ensuring this is recorded routinely alongside depressive 'disorder characteristics' in clinic may be important.

摘要

目的

确定年龄、性别和婚姻状况是否与在初级保健中寻求治疗的成年抑郁症患者的预后相关。

方法

从 Medline、Embase、PsycINFO 和 Cochrane Central 数据库中检索了从成立到 2020 年 12 月 1 日的随机对照试验(RCT),这些 RCT 针对的是从全科医生那里寻求治疗抑郁症的成年人,使用了修订后的临床访谈时间表,以便在临床预后因素的测量方面保持统一,并报告了年龄、性别和婚姻状况。从所有 9 项符合条件的 RCT 中收集了个体参与者数据(N=4864)。进行了两阶段随机效应荟萃分析,以确定以下方面之间的独立关联:(i)年龄,(ii)性别和(iii)婚姻状况,以及在基线后 3-4、6-8、<Vinod: Please carry out the deletion of serial commas throughout the article>和 9-12 个月时的抑郁症状和 3-4 个月时的缓解情况。使用 QUIPS 评估偏倚风险,并使用 GRADE 评估质量。PROSPERO 注册:CRD42019129512。预注册方案 https://osf.io/e5zup/。

结果

在调整与预后相关的抑郁“疾病特征”后,年龄与预后之间没有关联,这些特征与预后相关(症状严重程度、抑郁和焦虑持续时间、共患惊恐障碍和抗抑郁药治疗史)。年龄每增加 5 岁,在基线后 3-4 个月时的平均抑郁症状评分差异=0(95%CI:-0.02 至 0.02)。在基线后 3-4 个月或 9-12 个月时,男性和女性的预后没有差异,但男性在 6-8 个月时的预后较差(与女性相比,男性的抑郁症状差异百分比:15.08%(95%CI:4.82 至 26.35))。然而,这主要是由一项在 6-8 个月时提供数据的单一研究驱动的,而不是其他时间点。此外,在调整抑郁“疾病特征”和就业状况后,几乎没有证据表明存在关联(12.23%(95%CI:-1.69 至 28.12))。单身(单身参与者的抑郁症状差异百分比:9.25%(95%CI:2.78 至 16.13)或不再已婚(8.02%(95%CI:1.31 至 15.18))的参与者比已婚参与者的预后较差,即使在调整了抑郁“疾病特征”和所有可用的混杂因素后也是如此。

结论

临床医生和研究人员将继续常规记录年龄和性别,但尽管它们对抑郁症的发病率和患病率很重要,但它们似乎对预后提供的信息很少。单身或不再已婚的患者可能比已婚患者的预后稍差。确保在常规临床记录中与抑郁“疾病特征”一起记录这些信息可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b598/8192596/12614eeb0c54/S2045796021000342_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b598/8192596/12614eeb0c54/S2045796021000342_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b598/8192596/12614eeb0c54/S2045796021000342_fig1.jpg

相似文献

1
Role of age, gender and marital status in prognosis for adults with depression: An individual patient data meta-analysis.年龄、性别和婚姻状况对成年抑郁症预后的作用:一项个体患者数据荟萃分析。
Epidemiol Psychiatr Sci. 2021 Jun 4;30:e42. doi: 10.1017/S2045796021000342.
2
The contribution of depressive 'disorder characteristics' to determinations of prognosis for adults with depression: an individual patient data meta-analysis.抑郁“障碍特征”对成年抑郁症患者预后判断的影响:一项个体患者数据荟萃分析。
Psychol Med. 2021 May;51(7):1068-1081. doi: 10.1017/S0033291721001367. Epub 2021 Apr 14.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Socioeconomic Indicators of Treatment Prognosis for Adults With Depression: A Systematic Review and Individual Patient Data Meta-analysis.社会经济指标对成人抑郁症治疗预后的影响:系统评价和个体患者数据荟萃分析。
JAMA Psychiatry. 2022 May 1;79(5):406-416. doi: 10.1001/jamapsychiatry.2022.0100.
5
What factors indicate prognosis for adults with depression in primary care? A protocol for meta-analyses of individual patient data using the Dep-GP database.哪些因素可预示初级保健中成年抑郁症患者的预后?一项使用Dep-GP数据库对个体患者数据进行荟萃分析的方案。
Wellcome Open Res. 2020 Apr 1;4:69. doi: 10.12688/wellcomeopenres.15225.3. eCollection 2019.
6
Antidepressants for people with epilepsy and depression.抗抑郁药治疗癫痫合并抑郁患者。
Cochrane Database Syst Rev. 2021 Apr 16;4(4):CD010682. doi: 10.1002/14651858.CD010682.pub3.
7
Antidepressants for the treatment of depression in people with cancer.用于治疗癌症患者抑郁症的抗抑郁药。
Cochrane Database Syst Rev. 2018 Apr 23;4(4):CD011006. doi: 10.1002/14651858.CD011006.pub3.
8
Prevention of depression in adults with long-term physical conditions.预防长期躯体疾病成年人的抑郁。
Cochrane Database Syst Rev. 2021 Mar 5;3(3):CD011246. doi: 10.1002/14651858.CD011246.pub2.
9
Antidepressants for the treatment of depression in people with cancer.用于治疗癌症患者抑郁症的抗抑郁药。
Cochrane Database Syst Rev. 2015 Jun 1;2015(6):CD011006. doi: 10.1002/14651858.CD011006.pub2.
10
Psychological therapies for treatment-resistant depression in adults.成人难治性抑郁症的心理治疗
Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2.

引用本文的文献

1
Can working in agriculture have a favorable effect on depressive symptoms? Life satisfaction as a mediator.从事农业工作会对抑郁症状产生积极影响吗?生活满意度作为中介因素。
PLoS One. 2025 Aug 13;20(8):e0325912. doi: 10.1371/journal.pone.0325912. eCollection 2025.
2
Associations between pulmonary function and depression: evidence from the CHARLS cohort 2015-2018.肺功能与抑郁之间的关联:来自中国健康与养老追踪调查(CHARLS)2015 - 2018队列的证据。
Front Public Health. 2025 Jul 17;13:1551356. doi: 10.3389/fpubh.2025.1551356. eCollection 2025.
3
Screening for anxiety and depression among patients with cardiovascular diseases at a private tertiary care hospital in Karachi, Pakistan.

本文引用的文献

1
PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews.PRISMA-S:用于在系统评价中报告文献检索的 PRISMA 声明扩展。
J Med Libr Assoc. 2021 Apr 1;109(2):174-200. doi: 10.5195/jmla.2021.962.
2
The contribution of depressive 'disorder characteristics' to determinations of prognosis for adults with depression: an individual patient data meta-analysis.抑郁“障碍特征”对成年抑郁症患者预后判断的影响:一项个体患者数据荟萃分析。
Psychol Med. 2021 May;51(7):1068-1081. doi: 10.1017/S0033291721001367. Epub 2021 Apr 14.
3
What factors indicate prognosis for adults with depression in primary care? A protocol for meta-analyses of individual patient data using the Dep-GP database.
在巴基斯坦卡拉奇一家私立三级护理医院对心血管疾病患者进行焦虑和抑郁筛查。
Pak J Med Sci. 2025 Jun;41(6):1623-1628. doi: 10.12669/pjms.41.6.7978.
4
A review of the 257 meta-analyses of the differences between females and males in prevalence and risk, protective factors, and treatment outcomes for mental disorder.对257项关于女性和男性在精神障碍患病率、风险、保护因素及治疗结果方面差异的荟萃分析的综述。
BMC Psychiatry. 2025 Jul 3;25(1):677. doi: 10.1186/s12888-025-06848-7.
5
Social determinants of health and their impact on depression in family caregivers of those with dementia: The importance of intermediary determinants.健康的社会决定因素及其对痴呆症患者家庭照顾者抑郁的影响:中介决定因素的重要性。
Alzheimers Dement. 2025 Jun;21(6):e70325. doi: 10.1002/alz.70325.
6
Efficacy of Vortioxetine Versus Escitalopram on the Cognitive Profile of Patients With Depressive Disorder: A Comparative Study.伏硫西汀与艾司西酞普兰对抑郁症患者认知特征的疗效比较研究
Cureus. 2025 Feb 20;17(2):e79365. doi: 10.7759/cureus.79365. eCollection 2025 Feb.
7
The prevalence and determinants of alcohol use in the adult population of Tehran: insights from the Tehran Cohort Study (TeCS).德黑兰成年人群体中酒精使用的患病率及决定因素:来自德黑兰队列研究(TeCS)的见解
Clin Exp Med. 2025 Feb 18;25(1):63. doi: 10.1007/s10238-025-01581-7.
8
Psychological interventions for preventing relapse in individuals with partial remission of depression: a systematic review and individual participant data meta-analysis.预防抑郁症部分缓解个体复发的心理干预措施:系统评价与个体参与者数据荟萃分析
Psychol Med. 2025 Feb 17;55:e50. doi: 10.1017/S0033291725000157.
9
The protective role of employment in depression: insights from 2005 to 2018 NHANES information.就业在抑郁症中的保护作用:来自2005年至2018年美国国家健康与营养检查调查信息的见解。
Front Psychiatry. 2024 Dec 9;15:1455122. doi: 10.3389/fpsyt.2024.1455122. eCollection 2024.
10
Development and validation of a prognostic model to predict relapse in adults with remitted depression in primary care: secondary analysis of pooled individual participant data from multiple studies.开发和验证一个预测成人在初级保健中缓解期抑郁症复发的预后模型:来自多个研究的 pooled 个体参与者数据的二次分析。
BMJ Ment Health. 2024 Oct 28;27(1):e301226. doi: 10.1136/bmjment-2024-301226.
哪些因素可预示初级保健中成年抑郁症患者的预后?一项使用Dep-GP数据库对个体患者数据进行荟萃分析的方案。
Wellcome Open Res. 2020 Apr 1;4:69. doi: 10.12688/wellcomeopenres.15225.3. eCollection 2019.
4
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.舍曲林在初级保健中的临床疗效以及抑郁严重程度和病程的作用(PANDA):一项实用、双盲、安慰剂对照随机试验。
Lancet Psychiatry. 2019 Nov;6(11):903-914. doi: 10.1016/S2215-0366(19)30366-9. Epub 2019 Sep 19.
5
Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.探索性分析在重度抑郁症的抗抑郁治疗中的效应修饰因子:7 项安慰剂对照随机试验中 2803 名参与者的个体参与者数据荟萃分析。
J Affect Disord. 2019 May 1;250:419-424. doi: 10.1016/j.jad.2019.03.031. Epub 2019 Mar 6.
6
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).米氮平联合SSRIs 或 SNRIs 治疗初级保健中抗抑郁药治疗抵抗性抑郁症的 III 期随机安慰剂对照试验(MIR)。
BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218.
7
A systematic review and meta-analysis of interpersonal psychotherapy for perinatal women.围产期妇女人际心理治疗的系统评价和荟萃分析。
J Affect Disord. 2018 May;232:316-328. doi: 10.1016/j.jad.2018.01.018. Epub 2018 Feb 1.
8
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.21 种抗抑郁药治疗成人重度抑郁症的急性治疗的疗效和可接受性比较:系统评价和网络荟萃分析。
Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21.
9
Who benefits from psychotherapies for adult depression? A meta-analytic update of the evidence.哪些人从成人抑郁症的心理治疗中获益?证据的荟萃分析更新。
Cogn Behav Ther. 2018 Mar;47(2):91-106. doi: 10.1080/16506073.2017.1420098. Epub 2018 Jan 18.
10
Impact of demographic factors on the antidepressant effect: A patient-level data analysis from depression trials submitted to the Pharmaceuticals and Medical Devices Agency in Japan.人口统计学因素对抗抑郁疗效的影响:来自向日本药品和医疗器械管理局提交的抑郁症试验的患者水平数据分析。
J Psychiatr Res. 2018 Mar;98:116-123. doi: 10.1016/j.jpsychires.2017.12.019. Epub 2018 Jan 3.